{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:39:42Z","timestamp":1789871982112,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.jacl.2007.07.006","type":"journal-article","created":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T07:58:03Z","timestamp":1185868683000},"page":"256-263","source":"Crossref","is-referenced-by-count":77,"title":["Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B"],"prefix":"10.1016","volume":"1","author":[{"given":"Allan","family":"Sniderman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2007.07.006_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1953","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","author":"Mahley","year":"1995"},{"key":"10.1016\/j.jacl.2007.07.006_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7326\/0003-4819-82-2-158","article-title":"The biochemical, clinical and genetic features of type III hyperlipoproteinemia","volume":"82","author":"Morganroth","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0025-7125(16)31429-8","article-title":"Familial dysbetalipoproteinemia: new aspects of pathogenesis and diagnosis","volume":"66","author":"Havel","year":"1982","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.jacl.2007.07.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.8.1.1","article-title":"Apolipoprotein E polymorphism and atherosclerosis","volume":"8","author":"Davignon","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.jacl.2007.07.006_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-98-5-623","article-title":"NIH conference. Type III hyperlipoproteinemia. diagnosis, molecular defects, pathology and treatment","volume":"98","author":"Brewer","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib6","first-page":"1124","article-title":"Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2\/2","volume":"23","author":"Breslow","year":"1980","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2007.07.006_bib7","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1073\/pnas.79.15.4696","article-title":"Structured basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects","volume":"79","author":"Rall","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacl.2007.07.006_bib8","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1172\/JCI112704","article-title":"Familial apolipoproteinE deficiency","volume":"78","author":"Schaefer","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2007.07.006_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.metabol.2005.03.003","article-title":"Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations","volume":"54","author":"Tremblay","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2007.07.006_bib10","first-page":"1981","article-title":"Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia","volume":"45","author":"Wang","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.07.006_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2006.01616.x","article-title":"ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person\/ten-country panel","volume":"259","author":"Barter","year":"2006","journal-title":"J Int Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinchem\/40.4.586","article-title":"International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B","volume":"40","author":"Marcovina","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.07.006_bib13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1373\/clinchem.2004.047001","article-title":"Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations","volume":"51","author":"Blom","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.07.006_bib14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2007.07.006_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/clinchem\/24.6.853","article-title":"Multi-laboratory comparison of three heparin-M2+ precipitation procedures for estimating cholesterol in high-density lipoprotein","volume":"24","author":"Albers","year":"1978","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.07.006_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0026-0495(86)90146-0","article-title":"Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia","volume":"35","author":"Moorjani","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2007.07.006_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2007.07.006_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM196701052760107","article-title":"Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJM196701122760206","article-title":"Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM196701192760305","article-title":"Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJM196701262760406","article-title":"Fat transport in lipoproteinsan integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM196702022760507","article-title":"Fat transport in lipoproteins\u2014an integrated approach to mechanisms and disorders","volume":"276","author":"Fredrickson","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib23","first-page":"1977","article-title":"Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults","volume":"146","author":"Connelly","year":"1992","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.jacl.2007.07.006_bib24","first-page":"409","article-title":"Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan","volume":"15","author":"Connelly","year":"1999","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacl.2007.07.006_bib25","first-page":"892","article-title":"Dysbetalipoproteinaemia\u2014clinical and pathophysiological features","volume":"92","author":"Blom","year":"2002","journal-title":"S Afr Med J"},{"key":"10.1016\/j.jacl.2007.07.006_bib26","first-page":"104","article-title":"Clinical features of type III hyperlipoproteinaemia","volume":"26","author":"Stuyt","year":"1983","journal-title":"Neth J Med"},{"key":"10.1016\/j.jacl.2007.07.006_bib27","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1373\/clinchem.2006.070318","article-title":"Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the apoE2\/E2 genotype","volume":"52","author":"Martin-Campos","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2007.07.006_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20050110","article-title":"The adipocyte life cycle hypothesis","volume":"110","author":"Smith","year":"2006","journal-title":"Clin Sci"},{"key":"10.1016\/j.jacl.2007.07.006_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1073\/pnas.77.1.604","article-title":"Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]","volume":"77","author":"Sniderman","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9A","key":"10.1016\/j.jacl.2007.07.006_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2005.08.006","article-title":"Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B","volume":"96","author":"Stein","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287407001973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287407001973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T17:20:55Z","timestamp":1629480055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287407001973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1933287407001973"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2007.07.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}